Diagnostic Testing of STDs Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	160 Pages	Coherent Market Insights	June, 2023	CMI18107811

Best Price Guarantee
Price	from $4,500
Length	160 Pages
Publisher	Coherent Market Insights
Published Date	June, 2023
SKU	CMI18107811

Diagnostic Testing of STDs Market, By Test Type (Chlamydia, Gonorrhea, Syphilis, HIV, HPV+pap smear, HSV, and Chancroid), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Sexually Transmitted Diseases (STDs) are diseases that spread from person-to-person through sexual contact. Early identification or diagnosis of STDs can help stop further transmission. Laboratory tests can identify the cause and detect co-infections through blood tests, urine samples, swab tests, lumbar puncture, and fluids samples. Testing for a disease in someone who doesn't have symptoms is called screening. The screening can be done for a variety of infections like HIV, hepatitis B, chlamydia, syphilis, gonorrhea, and hepatitis C. Cervical cancer is often caused by certain strains of HPV. Treatment of STDs can be done by antibiotics and antiviral drugs which prevents the further spread of disease.

Market Dynamics

The increasing prevalence of STDs, government fundings for the treatment and management of STDs is expected to drive the global diagnostic testing of STDs market growth. For instance, on February 2, 2023, Mylab Discovery Solutions Pvt. Ltd., an India-based biotechnology company, launched rapid test kits for sexually transmitted diseases including human immunodeficiency virus (HIV), Hepatitis C virus (HCV), and syphilis. Among these tests, HIV 1/2 Ab, and HCV Ab are rapid tests for the detection of antibodies specific to HIV-1, HIV-2, and HCV respectively, while the syphilis antibody test detects antibodies (IgG, IgA, and IgM) to aid in the diagnosis of syphilis.

Key features of the study:

This report provides an in-depth analysis of the global diagnostic testing of STDs market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global diagnostic testing of STDs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgrade, market expansion, and marketing tactics
The global diagnostic testing of STDs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic testing of STDs market

Detailed Segmentation:

Global Diagnostic Testing of STDs Market, By Test Type:
Chlamydia
Gonorrhea
Syphilis
HIV
HPV+pap smear
HSV
Chancroid
Global Diagnostic Testing of STDs Market, By Region:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
U.K.
Germany
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
North Africa
Central Africa
South Africa
Company Profiles
Vela Diagnostics USA Inc.
Roche Holdings AG
Alere, Inc.
Becton Dickinson & Company
bioMerieux
Danaher Corporation (Beckman Coulter)
Hologic, Inc.
binx health
Chembio Diagnostics
Pinpoint Science Inc.
bioLytical Laboratories

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Test Type; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trend Analysis: Market Dynamics; Drivers; Restraints; Market Opportunities; Impact Analysis; Recent Product Launches; Epidemiology; Merger, Acquisition, and Collaborations; Regulatory Scenario; Key Developments; PEST Analysis
4. Global Diagnostic Testing of STDs Market– COVID-19 Impact Analysis: Economic Impact; COVID-19 Epidemiology; Impact on Supply and Demand
5. Global Diagnostic Testing of STDs Market, By Test Type, 2018–2030, (US$ Billion): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Chlamydia; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion); Gonorrhea; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion); Syphilis; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion); HIV; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion); HPV+ pap smear; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion); HSV; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion); Chancroid; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
6. Global Diagnostic Testing of STDs Market, By Region, 2018–2030, (US$ Billion): Introduction; Market Share Analysis, By Region, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Region, 2018–2030; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Billion); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Billion); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Billion); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Billion); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Billion); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018–2030, (US$ Billion); North Africa; Central Africa; South Africa
7. Competitive Landscape: Vela Diagnostics USA Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Roche Holdings AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Alere, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Becton Dickinson & Company; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; bioMerieux; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Danaher Corporation (Beckman Coulter); Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Hologic, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; binx health; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Chembio Diagnostics; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Pinpoint Science Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; bioLytical Laboratories; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies
8. Section: Research Methodology; About Us; *Browse 17 market data tables and 24 figures on “Diagnostic Testing of STDs Market” - Global forecast to 2030